Table 3.
Parameters | Controls | FU0 | FU1 | FU2 | FU3 |
---|---|---|---|---|---|
LVEF (%)a | 61.95 ± 5.25 | 62.25 ± 4.55 | 57.30 ± 3.20 | 60.97 ± 3.44 | 62.70 ± 4.78 |
LVEDV (mL) | 129.71 ± 20.79 | 134.49 ± 24.90 | 127.27 ± 21.15 | 125.80 ± 21.63 | 120.45 ± 19.85 |
LVESV (mL) | 49.44 ± 10.83 | 51.22 ± 11.09 | 55.37 ± 10.77 | 50.98 ± 11.73 | 48.43 ± 8.91 |
LVEDVI (mL/m2) | 73.28 ± 11.19 | 77.69 ± 10.27 | 74.13 ± 8.98 | 73.11 ± 11.07 | 71.09 ± 7.81 |
LVESVI (mL/m2) | 27.99 ± 6.21 | 29.62 ± 5.40 | 32.39 ± 5.95 | 29.29 ± 6.17 | 27.69 ± 3.67 |
LV mass (g) | 82.13 ± 15.63 | 79.71 ± 18.77 | 78.56 ± 16.19 | 76.91 ± 14.45 | 75.98 ± 13.34 |
GLS (%) | −15.29 ± 2.22 | −15.53 ± 1.68 | −14.13 ± 1.58 | −14.83 ± 1.40 | −15.05 ± 1.57 |
GRS (%) | 34.10 ± 6.23 | 34.18 ± 4.84 | 30.71 ± 5.19 | 32.52 ± 3.64 | 33.49 ± 5.96 |
GCS (%) | −19.40 ± 2.20 | −19.49 ± 1.69 | −18.23 ± 1.88 | −18.73 ± 1.30 | −19.18 ± 1.87 |
Global T1 value | 1,201.51 ± 37.92 | 1,212.86 ± 26.59 | 1,224.61 ± 39.13 | 1,243.47 ± 40.43 | 1,241.37 ± 26.02 |
Global T2 value | 40.65 ± 2.38 | 39.85 ± 1.95 | 39.64 ± 1.98 | 41.13 ± 2.64 | 39.54 ± 1.70 |
CMR, cardiac magnetic resonance; LV, left ventricular; LVEF, left ventricle ejection fraction; LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; LVEDVI, left ventricular end-diastolic volume index; LVESVI, left ventricular end-systolic volume index; GLS, global longitudinal strain; GCS, global circumferential strain; GRS, global radial strain; FU0, baseline; FU1, 2 days post radiotherapy; FU2, 3 months post radiotherapy; FU3, 6 months post radiotherapy.
Unless otherwise specified, data are mean ± SD. Data were compared among baseline and follow-ups by using the Friedman rank test with post-hoc test with Bonferroni correction. Data were compared between controls and baseline by using Student's t-tests or Mann–Whitney U test.
After using a post-hoc test with Bonferroni correction, none of those parameters had a significant difference among baseline and follow-ups.
P < 0.05 using Friedman rank test compared with baseline.